AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.450
-0.140 (-3.90%)
At close: Mar 6, 2026, 4:00 PM EST
3.495
+0.045 (1.30%)
After-hours: Mar 6, 2026, 7:55 PM EST
AbCellera Biologics Employees
AbCellera Biologics had 596 employees as of December 31, 2024. The number of employees increased by 10 or 1.71% compared to the previous year.
Employees
596
Change (1Y)
10
Growth (1Y)
1.71%
Revenue / Employee
$126,054
Profits / Employee
-$245,658
Market Cap
1.05B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 404 |
| Xeris Biopharma Holdings | 394 |
| Inhibrx Biosciences | 161 |
| Precigen | 143 |
| DBV Technologies | 117 |
| Inventiva | 84 |
| Taysha Gene Therapies | 73 |
| ArriVent BioPharma | 52 |
ABCL News
- 23 hours ago - AbCellera Biologics Inc. (ABCL) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 10 days ago - AbCellera Biologics Inc. (ABCL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - AbCellera Reports Full Year 2025 Business Results - Business Wire
- 23 days ago - AbCellera to Present at Upcoming Investor Conferences in March and April 2026 - Business Wire
- 6 weeks ago - AbCellera to Report Full Year 2025 Financial Results on February 24, 2026 - Business Wire
- 7 weeks ago - AbCellera Biologics Inc. (ABCL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - Business Wire
- 2 months ago - AbCellera and Bruker Reach Global Settlement of Patent Litigation - Business Wire